Maia Biotechnology Announces Clinical Supply Agreement With Beigene for Upcoming Phase 2 Trials in Three Cancer Indications
Maia生物技术宣布与百济神州签署临床供给协议,计划在三种癌症适应症中进行即将到来的第二阶段试验
Maia Biotechnology Announces Clinical Supply Agreement With Beigene for Upcoming Phase 2 Trials in Three Cancer Indications
Maia生物技术宣布与百济神州签署临床供给协议,计划在三种癌症适应症中进行即将到来的第二阶段试验
使用浏览器的分享功能,分享给你的好友吧